INTRA-CELLULAR THERAPIES INC earnings per share and revenue

23I earnings per share for the last quarter are -0.15 EUR whereas the estimation was -0.07 EUR which accounts for -117.29% surprise. Company revenue for the same period amounts to 192.45 M EUR despite the estimated figure of 186.82 M EUR. Estimated earnings per share for the next quarter are -0.08 EUR, and revenue is expected to reach 187.38 M EUR. Also watch annual changes over time to get a bigger picture of 23I earnings per share and revenue dynamics.